Biosciences Invest Advisor

Bright Minds Biosciences Organizes KOL Event Focused on Epilepsy Research Sep 19, 2024

Ventyx Biosciences Commences Phase 2a Trial for VTX3232 in Early Parkinson's Disease Patients Sep 6, 2024

Investigation Alert: BFA LLP Probing Ventyx Biosciences Executives for Potential Fiduciary Misconduct May 18, 2024